Get the latest tech news
The smart insulin pill that could change lives through anew method of nanotech-based insulin delivery
University of Sydney researchers are developing a nanotech-based oral insulin pill. Read more about how it’s providing hope for people with type 1 diabetes.
Victoria, with Professor David Le Couteur AO (MBBS ’81), in collaboration with UiT Norway Arctic University, discovered many years ago that it was possible to deliver medicines via nano-carriers to the liver. Victoria, Nick and David also co-founded Endo Axiom Pty Ltd, a spinout pharma-biotech company, which focuses on developing nanotechnology platforms for the delivery of therapeutic peptides, proteins, antigens and RNA. Professor Victoria Cogger Promising results have paved the way for the orally administered insulin to enter phase 1 human clinical trials this year, with the aim to be in the market by 2030.
Or read this on r/tech